ArticleTrials2019

Study protocol for a randomized, blinded, controlled trial of ketamine for acute painful crisis of sickle cell disease.

Mohammed S Alshahrani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.